Africa Rapid Diagnostic Tests (RDT) Market – Industry Trends and Forecast to 2030

请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

Africa Rapid Diagnostic Tests (RDT) Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Oct 2023
  • Country Level
  • 350 页面
  • 桌子數: 220
  • 图号: 60

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Africa Rapid Diagnostic Tests Rdt Market

市场规模(十亿美元)

CAGR :  % Diagram

Chart Image USD 1,272.52 Million USD 2,186.42 Million 2022 2030
Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1,272.52 Million
Diagram Market Size (Forecast Year)
USD 2,186.42 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Africa Rapid Diagnostic Tests (RDT) Market , By Product Type (Consumables and Kits, Instruments and Others), Mode (Professional Rapid Diagnostic Test Product and Over-The-Counter [OTC] Rapid Diagnostic Test Product), Technology (PCR-Based, Flow-Through Assays, Lateral Flow Immunochromatographic Assays, Agglutination Assay, Microfluidics, Substrate Technology and Others), Modality (Laboratory Based Test and Non-Laboratory Based Test), Age Group (Adult and Pediatric), Test Type (Determining Confirmation, Serological Testing and Viral Sequencing), Approach (In-Vitro Diagnostic and Molecular Diagnostic), Specimen (Swab, Blood, Urine, Saliva, Sputum and Others), Application (Infectious Disease Testing, Glucose Monitoring, Cardiology Testing, Oncology Testing, Cardiometabolic Testing, Drugs-of-Abuse Testing, Pregnancy and Fertility Testing, Toxicology Testing, and Others), End User (Hospital and Clinic, Diagnostic Laboratory, Home Care Setting, Research and Academic Institutes and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2030.

Africa Rapid Diagnostic Tests (RDT) Market Analysis and Size

The incidence of rapid diagnostic tests (RDTs) refers to the frequency or rate at which these tests are used or performed. However, it is important to note that the incidence of RDTs can vary greatly depending on the specific disease or condition being tested for, the geographic location, and the healthcare setting. The factors expected to drive the Africa rapid diagnostic tests (RDT) market are the increase in incidence in chronic diseases, rise in geriatric population, technological developments in the rapid diagnostic tests. Moreover, the strategic initiatives by market players and the rise in healthcare expenditure are expected to create opportunities for the Africa rapid diagnostic tests (RDT) market growth.

Data Bridge Market Research analyses that the Africa rapid diagnostic tests (RDT) market, which was USD 1,272.52 million in 2022, is expected to reach USD 2,186.42 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030.”Consumables and kits” segment dominates the product type segment of the Africa rapid diagnostic tests (RDT) market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Africa Rapid Diagnostic Tests (RDT) Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

产品类型(耗材及试剂盒、仪器及其他)、模式(专业快速诊断检测产品和非处方 [OTC] 快速诊断检测产品)、技术(基于 PCR、流通式检测、横向流动免疫色谱检测、凝集检测、微流体、底物技术及其他)、方式(实验室检测和非实验室检测)、年龄组(成人和儿童)、检测类型(确定确认、血清学检测和病毒测序)、方法(体外诊断和分子诊断)、样本(拭子、血液、尿液、唾液、痰液及其他)、应用(传染病检测、血糖监测、心脏病学检测、肿瘤学检测、心脏代谢检测、药物滥用检测、妊娠和生育能力检测、毒理学检测及其他)、最终用户(医院和诊所、诊断实验室、家庭护理环境、研究和学术机构等)、分销渠道(直接招标、零售等)

覆盖国家

南非、尼日利亚、埃塞俄比亚和非洲其他地区

涵盖的市场参与者

雅培(美国)、丹纳赫(美国)、赛莱克斯(美国)、AdvaCare Pharma(中国)、Access Bio(美国)、Cardinal Health(美国)、Bio-Rad Laboratories, Inc.(美国)、BD(美国)、F. Hoffmann-La Roche Ltd(瑞士)、bioMérieux SA(法国)、InBios International, Inc.(美国)、Gnomegen LLC(美国)、QIAGEN(荷兰)、Quidel Corporation(美国)、Chembio Diagnostics Systems, Inc.(美国)、Siemens Healthcare Gmbh(Siemens Healthineers AG 子公司)(德国)、PerkinElmer Inc.(美国)、Sekisui Diagnostics(美国)、Fujirebio(HU Group 子公司)(日本)、PTS Diagnostics(美国)、LamdaGen Corporation(美国)、Werfen(西班牙)、Nova Biomedical(美国)、Trinity Biotech(爱尔兰)、Sysmex Europe GmbH(Sysmex Corporation 子公司) (德国)、Luminex Corporation. A DiaSorin Company(美国)、MEGAKOR DIAGNOSTK GMBH(德国)

市场机会

  • 技术进步
  • 增强疾病控制意识和举措

市场定义

快速诊断检测又称为快速检测,是一种易于使用的检测,可在通常不到 20 分钟的时间内快速提供结果。与其他将诊断和采样送往实验室的标准和常规检测不同,快速诊断检测试剂盒的结果在护理点提供。护理点是患者接受治疗的地方。护理点可以是提供者的办公室、诊所或患者自己的家。快速诊断检测适用于诊断和检测传染病 (例如 COVID-19)、心脏病、肿瘤学、妊娠、生育能力检测、毒理学检测、药物滥用检测、心脏代谢检测和血糖监测。

非洲快速诊断测试 (RDT) 市场动态

驱动程序

  • 传染病发病率不断上升

疟疾、艾滋病毒/艾滋病、肺结核和呼吸道感染等传染病在全球的负担日益加重,推动了对快速诊断检测的需求。快速诊断检测能够快速准确地进行诊断,有助于及时治疗和管理这些疾病。

  • 即时诊断检测需求不断增长

即时检测的优势在于可以立即获得检测结果,无需实验室基础设施,并缩短了周转时间。快速诊断检测广泛应用于即时检测环境,例如诊所、医院和偏远地区,在这些地方,即时诊断至关重要。

  • 个性化医疗需求不断增长

个性化医疗侧重于根据个人的基因构成、生活方式和其他因素制定个性化治疗方案。快速诊断测试可用于识别特定生物标记、基因突变或耐药模式,从而实现个性化治疗方法。

机会

  • 技术进步和快速创新

科技进步推动了创新型快速诊断检测的发展,提高了准确性、灵敏度和特异性。例如,分子诊断技术与快速检测的结合提高了其性能并扩大了其应用范围。

  • 增强疾病控制意识和举措

政府和医疗机构正在实施各种措施来控制传染病的传播。快速诊断测试在这些计划中发挥着至关重要的作用,因为它可以实现早期发现、有效治疗和疾病监测。

限制/挑战

  • 敏感性和特异性的局限性

虽然快速诊断测试能快速得出结果,但与传统的实验室测试相比,其敏感性和特异性可能存在局限性。这可能导致假阳性或假阴性结果,影响诊断的准确性。

  • 监管挑战和要求

快速诊断测试需要满足严格的监管要求,以确保其安全性、有效性和质量。获得监管部门的批准可能是一个耗时且昂贵的过程,这可能会阻碍市场增长。

这份非洲快速诊断测试 (RDT) 市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关非洲快速诊断测试 (RDT) 市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

最新动态

  • 2021 年 6 月,Bio-Rad Laboratories, Inc. 与 Seegene, Inc. 合作,后者是多重分子诊断领域的全球领导者,致力于传染病分子诊断产品的临床开发和商业化。此次合作使该公司能够在全球范围内增加其销售额和产品线
  • 2020 年 3 月,丹纳赫完成了对通用电气生物制药业务的收购。未来,该业务将被称为 Cytiva,并成为丹纳赫生命科学部门内的一家独立运营公司。因此,这些收购有助于该公司实现其细分市场组合的多元化
  • 2020 年 12 月,Quidel Corporation 获得了美国食品药品监督管理局 (FDA) 的紧急批准,可使用 Quickvue Sars 快速抗原检测来诊断 COVID-19。该批准增加了 Quickvue Sars 快速抗原检测在医疗和护理点的分发,并获得了上市后批准

非洲快速诊断测试 (RDT) 市场范围

非洲快速诊断测试 (RDT) 市场根据产品类型、模式、技术、方式、年龄组、测试类型、方法、样本、应用、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

 产品类型

  • 耗材和套件
  • 仪器
  • 其他的

 模式

  • 专业快速诊断测试产品
  • 非处方 [OTC] 快速诊断检测产品

 技术

  • 基于PCR
  • 流通分析
  • 横向流动免疫层析检测
  • 凝集试验
  • 微流体
  • 基板技术
  • 其他的

情态

  • 实验室测试
  • 非实验室测试

 年龄组

  • 成人
  • 儿科

 测试类型

 方法

  • 体外诊断
  • 分子诊断

标本

  • 拭子
  • 尿
  • 唾液
  • 其他的

应用

  • 传染病检测
  • 血糖监测
  • 心脏病学检查
  • 肿瘤学检测
  • 心脏代谢测试
  • 药物滥用检测
  • 妊娠和生育测试
  • 毒理学测试
  • 其他的

最终用户

  • 医院和诊所
  • 诊断实验室
  • Home Care Setting
  • Research and Academic Institutes
  • Others

 Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

Africa Rapid Diagnostic Tests (RDT) Market Regional Analysis/Insights

The Africa rapid diagnostic tests (RDT) market is analysed and market size insights and trends are provided by country, product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel. as referenced above.

The countries covered in the Africa rapid diagnostic tests (RDT) market report are South Africa, Nigeria, Ethiopia and Rest of Africa

South Africa dominates the Africa rapid diagnostic tests (RDT) market because of the strong presence of major players in the market, rising demand of the   rapid diagnostic tests (RDT) products.

South Africa is expected to witness significant growth in the Africa rapid diagnostic tests (RDT) market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Africa rapid diagnostic tests (RDT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for   Africa rapid diagnostic tests (RDT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Africa rapid diagnostic tests (RDT) market. The data is available for historic period 2015-2020.

Competitive Landscape and Africa Rapid Diagnostic Tests (RDT) Market Share Analysis

The Africa rapid diagnostic tests (RDT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Africa rapid diagnostic tests (RDT) market.

Some of the major players operating in the Africa rapid diagnostic tests (RDT) market are:

  • Abbott (U.S.)
  • Danaher (U.S.)
  • Cellex (U.S.)
  • AdvaCare Pharma (China)
  • Access Bio (U.S.)
  • Cardinal Health (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • BD (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • bioMérieux SA (France)
  • InBios International, Inc. (U.S.)
  • Gnomegen LLC (U.S.)
  • QIAGEN (Netherlands)
  • Quidel Corporation (U.S.)
  • Chembio Diagnostics Systems, Inc. (U.S.)
  • Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG) (Germany)
  • PerkinElmer Inc. (U.S.)
  • Sekisui Diagnostics (U.S.)
  • Fujirebio (A Subsidiary of H.U. Group) (Japan)
  • PTS Diagnostics (U.S.)
  • LamdaGen Corporation (U.S.)
  • Werfen (Spain)
  • Nova Biomedical (U.S.)
  • Trinity Biotech (Ireland)
  • Sysmex Europe GmbH (A Subsidiary of Sysmex Corporation) (Germany)
  • Luminex Corporation. A DiaSorin Company (U.S.)
  • MEGAKOR DIAGNOSTK GMBH (Germany)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

The Africa rapid diagnostic tests (RDT) market size will be worth USD 2,186.42 million by 2030.
The growth rate of the Africa rapid diagnostic tests (RDT) market is 7.0% in the forecast period by 2030.
Increasing prevalence of infectious diseases, growing demand for point-of-care testing & growing demand for personalized medicine are the growth drivers of the Africa rapid diagnostic tests (RDT) market.
product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel are the factors on which the Africa rapid diagnostic tests (RDT) market research is based.
Major companies in the Africa rapid diagnostic tests (RDT) market are Abbott (U.S.), Danaher (U.S.), Cellex (U.S.), AdvaCare Pharma (China), Access Bio (U.S.), Cardinal Health (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux SA (France), InBios International, Inc. (U.S.), Gnomegen LLC (U.S.), QIAGEN (Netherlands), Quidel Corporation (U.S.), Chembio Diagnostics Systems, Inc. (U.S.), Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG) (Germany), PerkinElmer Inc. (U.S.), Sekisui Diagnostics (U.S.), Fujirebio (A Subsidiary of H.U. Group) (Japan), PTS Diagnostics (U.S.), LamdaGen Corporation (U.S.), Werfen (Spain), Nova Biomedical (U.S.), Trinity Biotech (Ireland), Sysmex Europe GmbH (A Subsidiary of Sysmex Corporation) (Germany), Luminex Corporation. A DiaSorin Company (U.S.), MEGAKOR DIAGNOSTK GMBH (Germany)
Testimonial